Rationale for Genetic Testing in Patients With Breast Cancer
Steven J. Katz, MD, MPH, discusses the benefits and challenges with genetic testing in patients with breast cancer.
Steven J. Katz, MD, MPH, professor of medicine and health management and policy at the University of Michigan, discusses the benefits and challenges with genetic testing in patients with breast cancer.
By identifying more genetic mutations in a patient, there is more understanding of the patient’s risk, says Katz. These pathogenic mutations and variances can be helpful in considering risk of cancer for both the patient and their family.
Breast Cancer Leans into the Decade of Antibody-Drug Conjugates, Experts Discuss
September 25th 2020In season 1, episode 3 of Targeted Talks, the importance of precision medicine in breast cancer, and how that vitally differs in community oncology compared with academic settings, is the topic of discussion.
Listen
